Day 1

Hypermethylation of RUFY1 associated with high risks of schizophrenia and poor treatment responses in Han ChineseWeihua Yue, China Frontal-posterior functional imbalance and aberrant function developmental patterns in schizophreniaFei Wang, China The role of white blood cell counts in metabolic changes and clinical symptom improvement after antipsychotics in patients with schizophrenia: evidence from a large Chinese …

Bipolar disorder is a complex psychiatric condition with pleomorphic presentations, varied course and high comorbidity. While several options are available for treating mania and preventing mania, many challenges remain in providing optimal outcomes for patients with bipolar disorder. For instance, treatment options continue to be limited for treating acute depressive symptoms in patients with bipolar …

Schizophrenia continues to present a major public health problem associated with enormous personal suffering, diminished functioning, family burden and societal costs. Although current treatments (ideally combinations of medication and psychosocial modalities) can substantially improve outcome for many affected individuals, a substantial subgroup qualifies as having “treatment resistant schizophrenia (TRS).” Estimates suggest that 15-20% of patients …

Welcome and Opening Ceremony

Lunch break and poster viewing

An evidence-based decision about a specific intervention (either pharmacological or not) is not determined only by its demonstrated efficacy and tolerability; it may vary from one patient to another depending on individual clinical circumstances (sex, age, clinical history, etc) and personal preferences. However, ‘evidence’ is not necessarily ‘evident’. Evidence is anything presented in support of …